Results 251 to 260 of about 96,364 (279)
Some of the next articles are maybe not open access.
Pneumococcal disease in childhood
Hospital Medicine, 2001Streptococcus pneumoniae is the most common cause of serious bacterial infections in children worldwide. Problems with antibiotic resistance have lead to changes in antibiotic policies for children with possible pneumococcal disease. Demonstration of the efficacy of a pneumococcal conjugate vaccine has lead to consideration of its inclusion in routine ...
P V, Mohan, P T, Heath
openaire +2 more sources
Current Opinion in Infectious Diseases, 2007
To describe the impact of highly active antiretroviral therapy on the burden of pneumococcal disease and advances in our understanding of the impact of HIV on this disease.Although highly active antiretroviral therapy has reduced the burden of pneumococcal disease among HIV-infected adults, these infections remain far more common than in HIV uninfected
Keith P, Klugman +2 more
openaire +2 more sources
To describe the impact of highly active antiretroviral therapy on the burden of pneumococcal disease and advances in our understanding of the impact of HIV on this disease.Although highly active antiretroviral therapy has reduced the burden of pneumococcal disease among HIV-infected adults, these infections remain far more common than in HIV uninfected
Keith P, Klugman +2 more
openaire +2 more sources
2003
The pneumococcus is now the most important bacterial pathogen causing pneumonia, meningitis, and otitis media. Traditional approaches to the diagnosis of Streptococcus pneumoniae as the etrologic agent causing these diseases include colony morphology, microscopy, optochin sensitivity, bile solubility, and inmunologic reaction with type-specific ...
A M, Smith, K P, Klugman
openaire +2 more sources
The pneumococcus is now the most important bacterial pathogen causing pneumonia, meningitis, and otitis media. Traditional approaches to the diagnosis of Streptococcus pneumoniae as the etrologic agent causing these diseases include colony morphology, microscopy, optochin sensitivity, bile solubility, and inmunologic reaction with type-specific ...
A M, Smith, K P, Klugman
openaire +2 more sources
Pneumococcal Disease after Pneumococcal Vaccination
New England Journal of Medicine, 1980Trials of pneumococcal vaccine in healthy young adult populations suggest 75 to 95 per cent type-specific efficacy. Trials have not been done, however, in groups for which pneumococcal vaccine is currently recommended in the United States. To assess efficacy in the immunocompromised groups now receiving the vaccine, we compared serotypes of 35 isolates
C V, Broome, R R, Facklam, D W, Fraser
openaire +2 more sources
Practice Nursing, 2008
Jeannett Martin reviews the risks of pneumococcal disease and the indications for vaccination
openaire +1 more source
Jeannett Martin reviews the risks of pneumococcal disease and the indications for vaccination
openaire +1 more source
Invasive Pneumococcal and Meningococcal Disease
Infectious Disease Clinics of North America, 2019This review focuses on current knowledge of the epidemiology, prevention, and treatment of invasive pneumococcal (IPD) and meningococcal disease (IMD). IPD decreased significantly with the introduction of effective conjugate vaccines but is on the rise again.
Deirdre, Fitzgerald, Grant W, Waterer
openaire +2 more sources
Independent Nurse, 2005
From April, all 65s and over will be eligible for pneumococcal vaccination.
openaire +1 more source
From April, all 65s and over will be eligible for pneumococcal vaccination.
openaire +1 more source
Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease
Pediatrics, 2015OBJECTIVE: Ten-valent pneumococcal conjugate vaccine (PCV10) was earlier shown to reduce clinically suspected, non–laboratory-confirmed invasive pneumococcal disease (IPD) in a cluster-randomized trial (the Finnish Invasive Pneumococcal disease trial).
Nuorti Pekka J +7 more
openaire +2 more sources